Antibacterial Activity of Traditional Medicinal Plants Used for the Treatment of Acute Diarrheal Diseases in Chiapas, Mexico
The <i>Enterobacteriaceae</i> family poses health risks due to its role in gastrointestinal diseases like acute diarrhea. With rising antibiotic resistance, plants offer promising antibacterial compounds with low toxicity. This study evaluated the antibacterial activity, minimum inhibito...
Saved in:
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Microbiology Research |
Subjects: | |
Online Access: | https://www.mdpi.com/2036-7481/16/1/10 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The <i>Enterobacteriaceae</i> family poses health risks due to its role in gastrointestinal diseases like acute diarrhea. With rising antibiotic resistance, plants offer promising antibacterial compounds with low toxicity. This study evaluated the antibacterial activity, minimum inhibitory concentration (MIC), and toxicity of ethanolic (EE) and aqueous (AE) extracts from five Mexican medicinal plants traditionally used in Chiapas for treating acute diarrheal diseases (ADD). Antibacterial activity was assessed using disk diffusion assays and MIC determined by macrodilution. Toxicity tests were performed using <i>Artemia salina</i>. As a result, EE extracts exhibited higher antibacterial activity than AE extracts. <i>Byrsonima crassifolia</i> effectively inhibited <i>Salmonella enteritidis</i> (78.26%, MIC 50 mg/mL) and <i>Shigella dysenteriae</i> (76.19%, MIC 25 mg/mL). <i>Solanum torvum</i> showed efficacy against <i>Escherichia coli</i> (55.55%, MIC 12.5 mg/mL) and <i>Salmonella enteritidis</i> (73.91%, MIC 25 mg/mL). <i>Euphorbia maculata</i> inhibited <i>Shigella dysenteriae</i> (104.76%, MIC 25 mg/mL), while <i>Guazuma ulmifolia</i> and <i>Bursera simaruba</i> exhibited no antibacterial effects. All extracts were non-toxic (LD<sub>50</sub> > 1000 μg/mL), indicating potential as natural alternatives for ADD treatment. |
---|---|
ISSN: | 2036-7481 |